Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gozes

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Trends in Neurosciences|November 24, 2001
Neuroprotective peptide drug delivery and development: potential new therapeuticsI Gozes
Neurochemistry International|May 22, 2010
Tubulin in the nervous systemI Gozes
Current Alzheimer Research|August 4, 2010
Tau pathology and future therapeuticsI Gozes
Endocrinology|December 1, 1986
Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating ratsI Gozes, Y Shani
Endocrinology|December 1, 1986
Detection of vasoactive intestinal peptide-encoding messenger ribonucleic acid in the rat ovariesI Gozes, A Tsafriri
The Journal of Clinical Investigation|September 1, 1992
A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat modelI Gozes, M Fridkin
Brain Research|April 25, 1994
Diurnal oscillation in vasoactive intestinal peptide gene expression independent of environmental light entrainingR Glazer, I Gozes
Molecular Neurobiology|January 1, 1989
VIP: molecular biology and neurobiological functionI Gozes, D E Brenneman
Journal of Molecular Neuroscience : MN|January 1, 1993
Neuropeptides as growth and differentiation factors in general and VIP in particularI Gozes, D E Brenneman
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982
Monoclonal antibodies that recognize discrete forms of tubulinI Gozes, C J Barnstable
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Trends in Neurosciences|November 24, 2001
Neuroprotective peptide drug delivery and development: potential new therapeuticsI Gozes
Neurochemistry International|May 22, 2010
Tubulin in the nervous systemI Gozes
Current Alzheimer Research|August 4, 2010
Tau pathology and future therapeuticsI Gozes
Endocrinology|December 1, 1986
Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating ratsI Gozes, Y Shani
Endocrinology|December 1, 1986
Detection of vasoactive intestinal peptide-encoding messenger ribonucleic acid in the rat ovariesI Gozes, A Tsafriri
The Journal of Clinical Investigation|September 1, 1992
A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat modelI Gozes, M Fridkin
Brain Research|April 25, 1994
Diurnal oscillation in vasoactive intestinal peptide gene expression independent of environmental light entrainingR Glazer, I Gozes
Molecular Neurobiology|January 1, 1989
VIP: molecular biology and neurobiological functionI Gozes, D E Brenneman
Journal of Molecular Neuroscience : MN|January 1, 1993
Neuropeptides as growth and differentiation factors in general and VIP in particularI Gozes, D E Brenneman
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982
Monoclonal antibodies that recognize discrete forms of tubulinI Gozes, C J Barnstable
Pageof 14